ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

CCOP Wins Vote Of Confidence From NCI Advisors

November 12, 2010

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011

NCI-Approved Clinical Trials

May 26, 2006

HHS Appoints 13 To Genetics Committee

January 17, 2003

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007